Healthcare & BiotechGRAIL Shares Drop 20% as UK's NHS Cancer Blood Test Trial Fails Its Primary GoalSalvado•May 27, 2026
Healthcare & PharmaceuticalsQuest Diagnostics' Haystack Oncology Deal Faces Repricing Risk as Validation Gaps Threaten $8B Liquid Biopsy Market EntryViaNews Editorial Team•Feb 22, 2026
